Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation-Reference-Cited by-同舟云学术

Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation

Published:2013-01 Issue:1 Volume:34 Page:53-59
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Vranckx Pascal,McFadden Eugene,Cutlip Donald E.,Mehran Roxana,Swart Michael,Kint P.P.,Zijlstra Felix,Silber Sigmund,Windecker Stephan,Serruys Patrick W.C.J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference11 articles.

1. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents;Serruys;N Engl J Med,2010

2. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial;Kedhi;Lancet,2010

3. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial;Windecker;Lancet,2008

4. Evaluating the ‘all-comers’ design: a comparison of participants in two ‘all-comers’ PCI trials with non-participants;de Boer;Eur Heart J,2011

5. The Academic Research Consortium (ARC) governance charter;Krucoff;JACC Cardiovasc Interv,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials;Circulation: Cardiovascular Quality and Outcomes;2021-11

2. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials;JACC: Cardiovascular Interventions;2019-05

3. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY);BMJ Open;2019-03

4. Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium;American Heart Journal;2017-08

5. A comparison of approaches for adjudicating outcomes in clinical trials;Trials;2017-06-08